Innate Pharma
IPHA
$2.71
Share price
5.44%
Change (1 day)
-7.20%
Change (1 year)
Categories
Market capitalization of Innate Pharma (IPHA)
Market cap: $0.21 Billion
As of May 2024 Innate Pharma has a market cap of $0.21 Billion. This makes Innate Pharma the world's 6885th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Innate Pharma from 2006 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.21 B | -4.85% |
| 2023 | $0.23 B | -23.05% |
| 2022 | $0.29 B | -25.31% |
| 2021 | $0.40 B | 19.1% |
| 2020 | $0.33 B | -36.08% |
| 2019 | $0.52 B | -3.37% |
| 2018 | $0.54 B | 67.19% |
| 2017 | $0.32 B | -60.86% |
| 2016 | $0.83 B | 4.46% |
| 2015 | $0.79 B | 56.64% |
| 2014 | $0.50 B | 62.46% |
| 2013 | $0.31 B | 187.53% |
| 2012 | $0.10 B | 111.61% |
| 2011 | $51.44 M | -11.96% |
| 2010 | $58.43 M | -54.99% |
| 2009 | $0.12 B | 160.81% |
| 2008 | $49.78 M | -45.82% |
| 2007 | $91.87 M | -35.67% |
| 2006 | $0.14 B |
End of Day market cap according to different sources
On May 19th, 2024 the market cap of Innate Pharma was reported to be:
$0.21 Billion
$0.21 Billion
$0.21 Billion
$0.21 Billion